jnj

Beyond the Blue Chips: Why Pharmaceutical Valuation Disconnects Matter In the world of pharmaceutical investing, the allure of a household name like Johnson & Johnson (JNJ) is undeniable. Investors often gravitate toward the comfort of massive market caps and diversified healthcare portfolios. However, savvy market participants know that the most compelling opportunities often hide in … Read more